Determinants of control of high blood pressure. The Oslo Health Study 2000–2001

Objective: To examine determinants of control of high blood pressure in Oslo, Norway. Methods: The Oslo Health Study 2000–2001, a population‐based survey, included 6301 men and 7645 women born in 1924/25, 1940/41, 1955 and 1960 that were screened for high blood pressure and other cardiovascular risk factors. Uncontrolled high blood pressure was defined as systolic >140 mmHg or diastolic >90 mmHg or both. Results: Use of antihypertensive drugs was 4.1% at age 40–45 years, 19.1% at age 60 years and 35.8% at age 75 years. Among pharmacologically treated subjects with diabetes or cardiovascular disease (CVD), one‐third of subjects aged 40–45 years, over one‐half of those aged 60 years and nearly two‐thirds of those aged 75 years had uncontrolled high blood pressure. These proportions were 8–13 percentage points higher in subjects without diabetes or CVD. Among pharmacologically treated men, younger age, use of statins, body mass index below 25 kg/m 2 , and CVD or diabetes were associated with a lower risk of uncontrolled high blood pressure. Among treated women, younger age and cigarette smoking were associated with a lower risk (p < 0.05). Conclusion: The presence of CVD or diabetes and the prescription of cholesterol‐lowering statins were independently associated with better control of blood pressure. Non‐smoking women were more likely to have uncontrolled high blood pressure than their smoking counterparts.

[1]  J. Tuomilehto,et al.  Patient report validated against prescription records for measuring use of and compliance with antihypertensive drugs. , 2009, Acta medica Scandinavica.

[2]  M. Kanbay,et al.  Statin Therapy Helps to Control Blood Pressure Levels in Hypertensive Dyslipidemic Patients , 2005, Renal failure.

[3]  E. Bjertness,et al.  The Oslo Health Study: The impact of self-selection in a large, population-based survey , 2004, International journal for equity in health.

[4]  D. Kromhout,et al.  Prevalence and determinants of undertreatment of hypertension in the Netherlands , 2004, Journal of Human Hypertension.

[5]  S. Tonstad,et al.  Undertreatment and overtreatment with statins: the Oslo Health Study 2000–2001 , 2004, Journal of internal medicine.

[6]  G. Berglund,et al.  Changes in blood pressure and body weight following smoking cessation in women , 2004, Journal of internal medicine.

[7]  R. Cooper,et al.  Hypertension Treatment and Control in Five European Countries, Canada, and the United States , 2004, Hypertension.

[8]  P. O’Connor Overcome clinical inertia to control systolic blood pressure. , 2003, Archives of internal medicine.

[9]  D. Berlowitz,et al.  Hypertension control: how well are we doing? , 2003, Archives of internal medicine.

[10]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[11]  G. Mancia,et al.  European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[12]  Ihab Hajjar,et al.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.

[13]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[14]  H. Hense,et al.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. , 2003, JAMA.

[15]  M. Glickman,et al.  Hypertension management in patients with diabetes: the need for more aggressive therapy. , 2003, Diabetes care.

[16]  P. Lapuerta,et al.  Physician-related barriers to the effective management of uncontrolled hypertension. , 2002, Archives of internal medicine.

[17]  B. Waeber,et al.  The multifactorial nature of hypertension: the greatest challenge for its treatment? , 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[18]  V. Pavlik,et al.  Characteristics of patients with uncontrolled hypertension in the United States. , 2001, The New England journal of medicine.

[19]  D. Jacobs,et al.  Effects of Smoking Cessation on Changes in Blood Pressure and Incidence of Hypertension: A 4-Year Follow-Up Study , 2001, Hypertension.

[20]  Emanuela Falaschetti,et al.  Association Between Smoking and Blood Pressure: Evidence From the Health Survey for England , 2001, Hypertension.

[21]  B. Waeber Treatment Strategy to Control Blood Pressure Optimally in Hypertensive Patients , 2001, Blood pressure.

[22]  E. Meland,et al.  [Pharmacological prevention of cardiovascular diseases in general practice]. , 2000, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[23]  R. Herings,et al.  Agreement between self‐reported antihypertensive drug use and pharmacy records in a population‐based study in The Netherlands , 1999, Pharmacy World and Science.

[24]  Ward Hj Inadequate management of blood pressure in a hypertensive population. , 1999, The New England journal of medicine.

[25]  T. Hedner,et al.  Smoking affects blood pressure. , 1996, Blood pressure.

[26]  G. Harari,et al.  A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. The Israeli CORDIS Study. , 1995, Journal of clinical epidemiology.

[27]  M. Edwardes,et al.  Confidence intervals for a binomial proportion by S. E. Vollset, Statistics in Medicine, 12, 809-824 (1993) , 1994, Statistics in medicine.

[28]  S E Vollset,et al.  Confidence intervals for a binomial proportion. , 1994, Statistics in medicine.

[29]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[30]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[31]  A. Donner,et al.  Assessing hypertension control in the community: the need for follow-up measurements to ensure clinical relevance. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[32]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice , 2004 .

[33]  A. Zanchetti,et al.  European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension , 2003 .

[34]  David R. Wood,et al.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. , 2001, European heart journal.

[35]  K. L. Linton,et al.  Trends in hypertension prevalence, treatment, and control: in a well-defined older population. , 1998, Hypertension.

[36]  J. Holmen,et al.  Implementing clinical guidelines in the treatment of hypertension in general practice. , 1998, Blood pressure.

[37]  A. Holen,et al.  Fifteen years with clinical guidelines in the treatment of hypertension--still discrepancies between intentions and practice. , 1997, Scandinavian journal of primary health care.